CN104450774A - Construction of soybean CRISPR/Cas9 system and application of soybean CRISPR/Cas9 system in soybean gene modification - Google Patents
Construction of soybean CRISPR/Cas9 system and application of soybean CRISPR/Cas9 system in soybean gene modification Download PDFInfo
- Publication number
- CN104450774A CN104450774A CN201410730236.0A CN201410730236A CN104450774A CN 104450774 A CN104450774 A CN 104450774A CN 201410730236 A CN201410730236 A CN 201410730236A CN 104450774 A CN104450774 A CN 104450774A
- Authority
- CN
- China
- Prior art keywords
- soybean
- crispr
- cas9
- cas9 system
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091033409 CRISPR Proteins 0.000 title claims abstract description 96
- 244000068988 Glycine max Species 0.000 title claims abstract description 79
- 235000010469 Glycine max Nutrition 0.000 title claims abstract description 79
- 238000010354 CRISPR gene editing Methods 0.000 title claims abstract description 45
- 238000012239 gene modification Methods 0.000 title abstract description 11
- 238000010276 construction Methods 0.000 title abstract description 10
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 40
- 238000000034 method Methods 0.000 claims abstract description 34
- 101150038500 cas9 gene Proteins 0.000 claims abstract description 8
- 239000013612 plasmid Substances 0.000 claims description 32
- 102000004190 Enzymes Human genes 0.000 claims description 15
- 108090000790 Enzymes Proteins 0.000 claims description 15
- 239000012634 fragment Substances 0.000 claims description 14
- 108091027544 Subgenomic mRNA Proteins 0.000 claims description 7
- 230000000295 complement effect Effects 0.000 claims description 6
- 238000013461 design Methods 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 238000000137 annealing Methods 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 claims description 2
- 108091008146 restriction endonucleases Proteins 0.000 claims 2
- 230000035772 mutation Effects 0.000 abstract description 16
- 230000008569 process Effects 0.000 abstract description 5
- 108020004414 DNA Proteins 0.000 description 40
- 210000001938 protoplast Anatomy 0.000 description 15
- 239000000047 product Substances 0.000 description 12
- 238000001962 electrophoresis Methods 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 238000012408 PCR amplification Methods 0.000 description 9
- 230000029087 digestion Effects 0.000 description 8
- 108010042407 Endonucleases Proteins 0.000 description 7
- 102000004533 Endonucleases Human genes 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000003776 cleavage reaction Methods 0.000 description 6
- 238000001976 enzyme digestion Methods 0.000 description 6
- 238000001502 gel electrophoresis Methods 0.000 description 6
- 230000005017 genetic modification Effects 0.000 description 6
- 235000013617 genetically modified food Nutrition 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 230000007017 scission Effects 0.000 description 6
- 230000009089 cytolysis Effects 0.000 description 5
- 238000010459 TALEN Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000010453 CRISPR/Cas method Methods 0.000 description 3
- 102000012410 DNA Ligases Human genes 0.000 description 3
- 108010061982 DNA Ligases Proteins 0.000 description 3
- 102100035102 E3 ubiquitin-protein ligase MYCBP2 Human genes 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 3
- 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000010362 genome editing Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 241000219194 Arabidopsis Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 108091028113 Trans-activating crRNA Proteins 0.000 description 2
- 108700019146 Transgenes Proteins 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000013611 chromosomal DNA Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000030279 gene silencing Effects 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000002741 site-directed mutagenesis Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010076491 BsaI endonuclease Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 231100001074 DNA strand break Toxicity 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000208966 Polygala Species 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 102000004389 Ribonucleoproteins Human genes 0.000 description 1
- 108010081734 Ribonucleoproteins Proteins 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000014155 detection of activity Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明属于植物分子生物学领域,涉及一种定点突变的体系,特别涉及一种大豆CRISPR/Cas9体系的构建及其在大豆基因修饰中的应用。The invention belongs to the field of plant molecular biology, and relates to a site-directed mutation system, in particular to the construction of a soybean CRISPR/Cas9 system and its application in soybean gene modification.
背景技术Background technique
对基因进行定点修饰,是生物研究领域重要的方法之一。随着科学的发展,越来越多的沉默技术发展迅速。从经典的MES随机诱变、T-DNA或转座子插入失活到锌指结构(ZFs)与转录激活因子样效应物核酸酶(TALENs)定点突变,这些技术都大大促进了研究基因功能的进程。但由于锌指核糖核酸酶(ZFN)与转录激活因子样效应物核酸酶(TALENs)技术需要针对每一个目的基因设计特定的内切酶,且构建过程繁琐,大大限制了其应用范围。与其他沉默体系相比,CRISPR定点突变技术有其无法比拟的优点,逐渐被广泛地应用与基因定点修饰研究中。Site-specific modification of genes is one of the most important methods in the field of biological research. With the development of science, more and more silencing techniques are developing rapidly. From classical MES random mutagenesis, T-DNA or transposon insertional inactivation to zinc finger structures (ZFs) and transcription activator-like effector nucleases (TALENs) site-directed mutagenesis, these techniques have greatly facilitated the study of gene function. process. However, zinc finger ribonuclease (ZFN) and transcription activator-like effector nuclease (TALENs) technologies need to design specific endonucleases for each target gene, and the construction process is cumbersome, which greatly limits their application range. Compared with other silencing systems, CRISPR site-directed mutagenesis technology has its incomparable advantages, and has gradually been widely used in the research of site-directed gene modification.
CRISPR/Cas体系最早是在大肠杆菌中发现的,是细菌针对噬菌体等外源DNA的获得性免疫系统。该系统主要依赖于crRNA与Cas蛋白形成的核糖核蛋白复合物识别靶序列上的PAM对入侵噬菌体或质粒进行特异性切割。CRISPR系统主要有三种类型,其中II型体系仅需要一个Cas9蛋白、crRNA与tracrRNA就能行使其功能。有研究表明将crRNA与tracrRNA整合成sgRNA并不影响CRISPR/Cas9体系的作用。2013年8月,自然生物技术期刊上首次同时发表了三篇有关CRISPR/Cas9体系成功应用于植物基因修饰的研究。之后,CRISPR/Cas9体系被广泛地应用于拟南芥、烟草、水稻、高粱、玉米及小麦研究上,但CRISPR/Cas9体系在大豆作物研究上仍是一片空白。The CRISPR/Cas system was first discovered in Escherichia coli, and it is the acquired immune system of bacteria against foreign DNA such as phages. This system mainly relies on the ribonucleoprotein complex formed by crRNA and Cas protein to recognize the PAM on the target sequence to specifically cut the invading phage or plasmid. There are three main types of CRISPR systems, among which the type II system only needs a Cas9 protein, crRNA and tracrRNA to perform its function. Studies have shown that integrating crRNA and tracrRNA into sgRNA does not affect the function of the CRISPR/Cas9 system. In August 2013, three studies on the successful application of the CRISPR/Cas9 system to plant genetic modification were simultaneously published in the journal Nature Biotechnology for the first time. Since then, the CRISPR/Cas9 system has been widely used in the research of Arabidopsis thaliana, tobacco, rice, sorghum, corn and wheat, but the CRISPR/Cas9 system is still blank in the research of soybean crops.
大豆[Glycine max(L.)Merr.]是重要的农作物之一,是植物蛋白与食用油的主要来源,营养价值与经济价值较高。为更好地研究基因功能,经常需要进行特定位点的基因突变,而现有的ZFNs体系过于复杂、费时且效率低,大大限制了该方法的应用。因此,发展一种针对大豆的CRISPR/Cas体系,并将其应用在大豆基因修饰领域显得尤为重要。Soybean [Glycine max(L.)Merr.] is one of the important crops and the main source of vegetable protein and edible oil, with high nutritional and economic value. In order to better study gene function, it is often necessary to carry out gene mutation at a specific site, but the existing ZFNs system is too complicated, time-consuming and inefficient, which greatly limits the application of this method. Therefore, it is particularly important to develop a soybean-specific CRISPR/Cas system and apply it in the field of soybean genetic modification.
发明内容Contents of the invention
本发明的第一目的是提供一种大豆CRISPR/Cas9体系的构建,解决目前大豆尚无CRISPR/Cas体系,而ZFNs体系过于复杂,费时且效率低的问题。The first object of the present invention is to provide a construction of a soybean CRISPR/Cas9 system, which solves the problems that there is no CRISPR/Cas system in soybean at present, and the ZFNs system is too complicated, time-consuming and inefficient.
本发明的第二目的是提供上述大豆CRISPR/Cas9体系在大豆基因修饰中的应用。The second object of the present invention is to provide the application of the above soybean CRISPR/Cas9 system in soybean genetic modification.
本发明通过以下技术方案来实现:The present invention is realized through the following technical solutions:
一、一种大豆CRISPR/Cas9体系的构建,该方法包括以下步骤:One, the construction of a soybean CRISPR/Cas9 system, the method comprises the following steps:
(1)将cas9构建到pCambia3301载体上;(1) Cas9 is constructed on the pCambia3301 vector;
(2)人工合成带有大豆特异U6-10启动子的sgRNAs,大豆特异U6-10启动子和sgRNAs之间带有两个BsaI酶切位点;(2) Artificially synthesize sgRNAs with a soybean-specific U6-10 promoter, with two BsaI restriction sites between the soybean-specific U6-10 promoter and sgRNAs;
(3)根据大豆目的基因设计核心序列,根据核心序列合成两端带有与BsaI酶切后形成的粘性末端互补序列的引物;(3) Designing a core sequence according to the soybean target gene, and synthesizing primers with a cohesive end complementary sequence formed after digestion with BsaI at both ends according to the core sequence;
(4)将步骤(2)合成的片段连接入pUC57-Kan质粒,提取质粒后,用BsaI内切酶完全酶切;(4) The fragment synthesized in step (2) is connected into the pUC57-Kan plasmid, and after the plasmid is extracted, it is completely digested with BsaI endonuclease;
(5)将步骤(3)合成的引物退火后结合成的带有粘性末端的核心序列,与步骤(4)酶切后的片段相连接;(5) linking the core sequence with cohesive ends formed by annealing the primers synthesized in step (3) to the fragment after digestion in step (4);
(6)酶切步骤(5)连接后的质粒,获得目的片段构建到带有cas9的pCambia3301载体上,获得pCas9-GmU6-sgRNA。(6) Digest the plasmid after ligation in step (5) to obtain the target fragment and construct it on the pCambia3301 vector with cas9 to obtain pCas9-GmU6-sgRNA.
二、上述的大豆CRISPR/Cas9体系在大豆基因修饰中的应用。2. Application of the above soybean CRISPR/Cas9 system in soybean genetic modification.
采用上述技术方案的积极效果:本发明所构建的大豆CRISPR/Cas9体系简单,对大豆基因修饰能够快速、高效的完成,克服了现有的ZFNs体系过于复杂,费时且效率低的问题;且通过实验证明,将大豆CRISPR/Cas9体系与大豆子叶节发根法或大豆原生质体法结合,突变率更高,更加有利于对大豆基因,尤其是与大豆根或根瘤相关基因功能的研究。The positive effect of adopting the above technical solution: the soybean CRISPR/Cas9 system constructed by the present invention is simple, and the soybean genetic modification can be completed quickly and efficiently, and overcomes the problems that the existing ZFNs system is too complicated, time-consuming and inefficient; and through Experiments have shown that the combination of soybean CRISPR/Cas9 system with soybean cotyledon rooting method or soybean protoplast method has a higher mutation rate, which is more conducive to the study of soybean genes, especially the functions of genes related to soybean roots or root nodules.
附图说明Description of drawings
图1是本发明的CRISPR/Cas9载体示意图;Fig. 1 is a schematic diagram of the CRISPR/Cas9 carrier of the present invention;
图2是大豆原生质体法检测的CRISPR/Cas9体系对Glyma06g14180编辑情况的凝胶电泳图;Figure 2 is a gel electrophoresis image of the editing of Glyma06g14180 by the CRISPR/Cas9 system detected by the soybean protoplast method;
图中,M:marker;1:将CRISPR/Cas9载体转入到大豆原生质体48小时后,提取基因组DNA,Pst I完全酶切后,PCR扩增Glyma06g14180电泳;2:叶片基因组DNA,Pst I完全酶切后,PCR扩增Glyma06g14180电泳;3:叶片基因组DNA,PCR扩增Glyma06g14180后电泳;In the figure, M: marker; 1: 48 hours after the CRISPR/Cas9 vector was transferred into soybean protoplasts, the genomic DNA was extracted, and Pst I was digested completely, then PCR amplified Glyma06g14180 electrophoresis; 2: Genomic DNA of leaves, Pst I was completely digested After enzyme digestion, PCR amplification of Glyma06g14180 and electrophoresis; 3: Leaf genomic DNA, PCR amplification of Glyma06g14180 and electrophoresis;
图3是大豆原生质体法检测的CRISPR/Cas9体系对Glyma08g02290编辑情况的凝胶电泳图;Figure 3 is a gel electrophoresis image of the editing of Glyma08g02290 by the CRISPR/Cas9 system detected by the soybean protoplast method;
图中,M:marker;1:将CRISPR/Cas9载体转入到大豆原生质体48小时后,提取基因组DNA,BamH I完全酶切后,PCR扩增Glyma08g02290电泳;2:叶片基因组DNA,BamH I完全酶切后,PCR扩增Glyma08g02290电泳;3:叶片基因组DNA,PCR扩增Glyma08g02290后电泳;In the figure, M: marker; 1: 48 hours after the CRISPR/Cas9 vector was transferred into soybean protoplasts, the genomic DNA was extracted, and after BamH I complete digestion, PCR amplified Glyma08g02290 electrophoresis; 2: Leaf genomic DNA, BamH I complete After enzyme digestion, PCR amplification of Glyma08g02290 and electrophoresis; 3: Leaf genomic DNA, PCR amplification of Glyma08g02290 and electrophoresis;
图4是大豆原生质体法检测的CRISPR/Cas9体系对Glyma12g37050编辑情况的凝胶电泳图;Figure 4 is a gel electrophoresis image of the editing of Glyma12g37050 by the CRISPR/Cas9 system detected by the soybean protoplast method;
图中,M:marker;1:将CRISPR/Cas9载体转入到大豆原生质体48小时后,提取基因组DNA,EcoR I完全酶切后,PCR扩增Glyma12g37050电泳;2:叶片基因组DNA,EcoR I完全酶切后,PCR扩增Glyma12g37050电泳;3:叶片基因组DNA,PCR扩增Glyma12g37050后电泳;In the figure, M: marker; 1: 48 hours after the CRISPR/Cas9 vector was transferred into soybean protoplasts, the genomic DNA was extracted, and EcoR I was digested completely, then PCR amplified Glyma12g37050 electrophoresis; 2: Genomic DNA of leaves, EcoR I completely After enzyme digestion, PCR amplification of Glyma12g37050 and electrophoresis; 3: Leaf genomic DNA, PCR amplification of Glyma12g37050 and electrophoresis;
图5是大豆子叶节诱导发根法检测的CRISPR/Cas9体系对Glyma06g14180编辑情况的凝胶电泳图;Figure 5 is a gel electrophoresis image of Glyma06g14180 edited by the CRISPR/Cas9 system detected by the soybean cotyledon node-induced hairy root method;
图中,M:marker;wt1:叶片基因组DNA,PCR扩增Glyma06g14180后,用PstI酶切电泳;wt2:叶片基因组DNA,PCR扩增Glyma06g14180片段;1-21:诱导形成的发状根,提取的基因组DNA,PCR扩增Glyma06g14180后,用Pst I酶切电泳;其中4和7为阳性发状根。In the figure, M: marker; wt1: leaf genomic DNA, Glyma06g14180 was amplified by PCR, and electrophoresed with PstI; wt2: leaf genomic DNA, Glyma06g14180 fragment was amplified by PCR; 1-21: induced hairy roots, extracted Genomic DNA, after PCR amplification of Glyma06g14180, was digested with Pst I and electrophoresed; 4 and 7 were positive hairy roots.
图6是大豆子叶节发根法检测的CRISPR/Cas9体系对Glyma08g02290编辑情况的凝胶电泳图;Figure 6 is a gel electrophoresis image of Glyma08g02290 edited by the CRISPR/Cas9 system detected by the soybean cotyledonary node hairy root method;
图中,M:marker;wt1:叶片基因组DNA,PCR扩增Glyma08g02290片段;wt2:叶片基因组DNA,PCR扩增Glyma08g02290后,用BamH I酶切电泳;1-21:诱导形成的发状根,提取的基因组DNA,PCR扩增Glyma08g02290后,用BamH I酶切电泳;其中11、12、13、18和19为阳性发状根。In the figure, M: marker; wt1: leaf genomic DNA, Glyma08g02290 fragment amplified by PCR; wt2: leaf genomic DNA, PCR amplified Glyma08g02290, electrophoresed with BamH I; 1-21: induced hairy root, extracted Genomic DNA of Glyma08g02290 was amplified by PCR, and digested with BamHI and electrophoresed; 11, 12, 13, 18 and 19 were positive hairy roots.
图7是大豆子叶节发根法检测的CRISPR/Cas9体系对Glyma12g37050编辑情况的凝胶电泳图;Figure 7 is a gel electrophoresis image of Glyma12g37050 edited by the CRISPR/Cas9 system detected by the soybean cotyledonary node hairy root method;
图中,M:marker;wt1:叶片基因组DNA,PCR扩增Glyma12g37050片段;wt2:叶片基因组DNA,PCR扩增Glyma12g37050后,用EcoR I酶切电泳;1-21:诱导形成的发状根,提取的基因组DNA,PCR扩增Glyma12g37050后,用EcoR I酶切电泳;其中1、5、8、14、19为阳性发状根。In the figure, M: marker; wt1: leaf genomic DNA, PCR amplified Glyma12g37050 fragment; wt2: leaf genomic DNA, PCR amplified Glyma12g37050, electrophoresed with EcoR I; 1-21: induced hairy roots, extracted Genomic DNA of Glyma12g37050 was amplified by PCR, and digested with EcoRI and electrophoresed; 1, 5, 8, 14, and 19 were positive hairy roots.
图8是带有拟南芥特异U6-26启动子的CRISPR/Cas9体系构建示意图。Figure 8 is a schematic diagram of the construction of the CRISPR/Cas9 system with the Arabidopsis-specific U6-26 promoter.
具体实施方式Detailed ways
本发明的生物材料的来源:Sources of biological material of the present invention:
1、载体pH-Ubi-cas9-7:Targeted mutagenesis in rice using CRISPR-Cas system,JinMiao,Dongshu Guo,Jinzhe Zhang,Qingpei Huang,Genji Qin,Xin Zhang,Jianmin Wan,Hongya Gu,Li-Jia Qu,Cell Research(2013)23:1233-1236,该载体由瞿礼嘉教授赠送给本专利的申请人;1. Carrier pH-Ubi-cas9-7: Targeted mutagenesis in rice using CRISPR-Cas system, JinMiao, Dongshu Guo, Jinzhe Zhang, Qingpei Huang, Genji Qin, Xin Zhang, Jianmin Wan, Hongya Gu, Li-Jia Qu, Cell Research (2013) 23:1233-1236, the carrier was presented to the applicant of this patent by Professor Qu Lijia;
2、载体pCambia3301:购于北京基尼亚生物技术有限公司;2. Vector pCambia3301: purchased from Beijing Genia Biotechnology Co., Ltd.;
3、所有引物为自行设计并委托三博远志生物技术有限公司合成。3. All primers were designed by ourselves and synthesized by Sanbo Yuanzhi Biotechnology Co., Ltd.
下面结合实施例和对比例对本发明的技术方案做进一步的说明,但不应理解为对本发明的限制:Below in conjunction with embodiment and comparative example technical scheme of the present invention will be further described, but should not be interpreted as limiting the present invention:
实施例1Example 1
本实施例用于说明大豆CRISPR/Cas9体系的构建过程。This example is used to illustrate the construction process of soybean CRISPR/Cas9 system.
(1)挑取含有pCambia3301质粒的单菌落,接种于50ml LB液体培养基中,培养基中加入卡那青霉素至终浓度为100ng/ml,37℃、200转速摇床中过夜培养。(1) Pick a single colony containing the pCambia3301 plasmid, inoculate it in 50ml LB liquid medium, add kanapenicillin to the medium to a final concentration of 100ng/ml, and culture overnight in a shaker at 37°C and 200 rpm.
(2)收集菌落,通过碱裂解法提取pCambia3301质粒,通过分光光度计测定质粒浓度,并将浓度调节至200ng/ul。(2) Collect colonies, extract pCambia3301 plasmid by alkaline lysis, measure the plasmid concentration by spectrophotometer, and adjust the concentration to 200ng/ul.
(3)取步骤(2)中5ug pCambia3301质粒,用NcoI和PmlI酶(Fermentas)双酶切过夜。(3) Get the 5ug pCambia3301 plasmid in step (2), and use NcoI and PmlI enzymes (Fermentas) to digest overnight.
(4)将酶切产物在0.8%琼脂糖胶上电泳,用胶纯化回收试剂盒(Tiangen)回收pCambia3301质粒双酶切后的大片段DNA。分光光度计测定回收的pCambia3301大片段DNA浓度,将浓度调节为50ng/ul。(4) The digested product was electrophoresed on a 0.8% agarose gel, and the large DNA fragment after double digestion of the pCambia3301 plasmid was recovered with a gel purification recovery kit (Tiangen). The concentration of the recovered pCambia3301 large fragment DNA was measured by a spectrophotometer, and the concentration was adjusted to 50ng/ul.
(5)以瞿礼嘉教授提供的pH-Ubi-Cas9-7质粒为模板,用高保真DNA phusion酶(NEB)和Cas9特异引物(Cas9-F:CATGccatggCCCCAAAGAAGAAGCGC和Cas9-RTCAATCGCCGCCGAGTTGTGA)扩增Cas9基因。(5) Using the pH-Ubi-Cas9-7 plasmid provided by Professor Qu Lijia as a template, the Cas9 gene was amplified with high-fidelity DNA phusion enzyme (NEB) and Cas9-specific primers (Cas9-F: CATGccatggCCCCAAAGAAGAAGCGC and Cas9-RTCAATCGCCGCCGAGTTGTGA).
(6)将扩增的Cas9DNA用PCR产物纯化试剂盒(Tiagen)进行纯化,通过分光光度计将其浓度调节至100ng/ul。(6) The amplified Cas9 DNA was purified with a PCR product purification kit (Tiagen), and its concentration was adjusted to 100 ng/ul by a spectrophotometer.
(7)用NcoI酶(Fermenata)对Cas9DNA进行酶切过夜,酶切产物用PCR产物纯化试剂盒(Tiagen)进行纯化,通过分光光度计将其浓度调节至100ng/ul。(7) Cas9DNA was digested overnight with NcoI enzyme (Fermenata), and the digested product was purified with a PCR product purification kit (Tiagen), and its concentration was adjusted to 100 ng/ul by a spectrophotometer.
(8)取来源于(7)的100ng Cas9DNA与来源于步骤(4)的100ng pCambia3301大片段DNA混合后,加入1个单位的T4DNA连接酶进行16℃连接过夜形成pCambia3301-Cas9质粒。(8) After mixing 100ng Cas9DNA derived from (7) with 100ng pCambia3301 large fragment DNA derived from step (4), add 1 unit of T4 DNA ligase for 16°C ligation overnight to form pCambia3301-Cas9 plasmid.
(9)取2ul步骤(8)的连接产物,与50ul的DH10β感受态细胞混匀,冰上放置30分钟,42℃90秒,加入800ul LB液体培养基,37℃、200转培养50分钟,3000转离心、去上清,将沉淀的DH10β细胞重悬后均匀涂布于含有100ng/ml卡那青霉素的培养基中,37℃培养过夜。(9) Take 2 ul of the ligation product of step (8), mix it with 50 ul of DH10β competent cells, place it on ice for 30 minutes, add 800 ul of LB liquid medium for 90 seconds at 42°C, and incubate at 37°C and 200 rpm for 50 minutes. Centrifuge at 3000 rpm, remove the supernatant, resuspend the precipitated DH10β cells, spread evenly in the medium containing 100ng/ml kanapenicillin, and culture overnight at 37°C.
(10)挑取单菌落,用pCambia3301引物(GATCCCTAAGCTTGGCAAGTTCC)和Cas9基因引物(AGTTGGGCGATCAGATTCTC)进行菌落PCR验证Cas9是否与pCambia3301连接,挑取阳性克隆于50ml,卡那青霉素至终浓度为100ng/ml的LB液体培养基中,37℃、200转速摇床中过夜培养。(10) Pick a single colony, use pCambia3301 primers (GATCCCTAAGCTTGGCAAGTTCC) and Cas9 gene primers (AGTTGGGCGATCAGATTCTC) to carry out colony PCR to verify whether Cas9 is connected to pCambia3301, pick positive clones in 50ml, kanapenicillin to LB with a final concentration of 100ng/ml In liquid culture medium, cultivate overnight at 37°C in a shaker at 200 rpm.
(11)收集菌落,通过碱裂解法提取pCambia3301-Cas9质粒,通过分光光度计测定质粒浓度,并将浓度调节至200ng/ul备用。(11) Collect colonies, extract the pCambia3301-Cas9 plasmid by alkaline lysis, measure the concentration of the plasmid by a spectrophotometer, and adjust the concentration to 200ng/ul for later use.
(12)在Genscript公司进行人工合成带有大豆特异U6-10启动子的sgRNAs,该片段位于pUC57-Kan质粒的EcoRI和HindIII酶切位点之间,形成pUC57-GmU6-sgRNA质粒。在大豆特异U6-10启动子和sgRNAs之间带有两个BsaI酶切位点;两个BsaI酶切位点联合作用,使得酶切后将酶切位点序列全部切除;(12) sgRNAs with soybean-specific U6-10 promoter were artificially synthesized in Genscript Company, and the fragment was located between the EcoRI and HindIII restriction sites of pUC57-Kan plasmid to form pUC57-GmU6-sgRNA plasmid. There are two BsaI enzyme cutting sites between the soybean-specific U6-10 promoter and sgRNAs; the two BsaI enzyme cutting sites work together to remove all the enzyme cutting site sequences after enzyme digestion;
(13)碱裂解法提取pUC57-GmU6-sgRNA质粒,用分光光度计调节质粒浓度至100ng/ul备用。(13) The pUC57-GmU6-sgRNA plasmid was extracted by alkaline lysis, and the plasmid concentration was adjusted to 100 ng/ul with a spectrophotometer for later use.
(14)取1ug步骤(13)中制备的质粒,用BsaI酶37℃酶切过夜,用PCR产物纯化试剂盒(Tiagen)进行纯化,用分光光度计调节质粒浓度至100ng/ul备用。(14) Take 1 ug of the plasmid prepared in step (13), digest it with BsaI enzyme at 37°C overnight, purify it with a PCR product purification kit (Tiagen), and adjust the plasmid concentration to 100 ng/ul with a spectrophotometer for later use.
(15)根据大豆目的基因设计核心序列互补引物,核心序列合成两端带有与BsaI酶切后形成的粘性末端互补的序列。分别取1ug互补引物于10ul TE中,90℃5分钟、然后缓慢的降温使互补引物配对形成带有BsaI酶粘性末端的双链DNA。(15) Design primers complementary to the core sequence according to the soybean target gene, and the two ends of the core sequence are synthesized with sequences complementary to the cohesive ends formed after digestion with BsaI. Take 1ug of complementary primers in 10ul TE, 90°C for 5 minutes, and then slowly lower the temperature to make the complementary primers pair to form double-stranded DNA with BsaI enzyme sticky ends.
(16)取1ug步骤(15)复性的双链DNA与100ng步骤(14)的pUC57-GmU6-sgRNA质粒,在T4DNA连接酶作用下,16℃连接过夜。(16) Take 1 ug of the double-stranded DNA refolded in step (15) and 100 ng of the pUC57-GmU6-sgRNA plasmid in step (14), and ligate overnight at 16° C. under the action of T4 DNA ligase.
(17)取2ul步骤(16)的连接产物,与50ul的DH10β感受态细胞混匀,冰上放置30分钟,42℃90秒,加入800ul LB液体培养基,37℃、200转培养50分钟,3000转离心、去上清,将沉淀的DH10β细胞重悬后均匀涂布于含有100ng/ml卡那青霉素的培养基中,37℃培养过夜。(17) Take 2 ul of the ligation product of step (16), mix it with 50 ul of DH10β competent cells, place it on ice for 30 minutes, add 800 ul of LB liquid medium for 90 seconds at 42°C, and incubate at 37°C and 200 rpm for 50 minutes. Centrifuge at 3000 rpm, remove the supernatant, resuspend the precipitated DH10β cells, spread evenly in the medium containing 100ng/ml kanapenicillin, and culture overnight at 37°C.
(18)挑取单菌落,用M13F(cgccagggttttcccagtcacgac)和M13R(agcggataacaatttcacacagga)引物进行菌落PCR扩增验证插入片段。挑取阳性克隆进行测序(三博远志生物技术有限公司)验证序列的完整性。(18) Pick a single colony, use M13F (cgccagggttttcccagtcacgac) and M13R (agcggataacaatttcacacagga) primers to perform colony PCR amplification to verify the insert. Pick positive clones for sequencing (Sanbo Polygala Biotechnology Co., Ltd.) to verify the integrity of the sequence.
(19)挑取步骤(18)序列正确的克隆,接种于50ml、卡那青霉素终浓度为100ng/ml的LB液体培养基中,37℃、200转速摇床中过夜培养。碱裂解法提取质粒后,用分光光度计调节质粒浓度至100ng/ul。(19) Pick the clone with the correct sequence in step (18), inoculate it in 50 ml of LB liquid medium with a final concentration of kanapenicillin of 100 ng/ml, and culture overnight at 37° C. in a shaker at 200 rpm. After the plasmid was extracted by alkaline lysis, the concentration of the plasmid was adjusted to 100 ng/ul with a spectrophotometer.
(20)取100ng步骤(11)的pCambia3301-Cas9质粒DNA和100ng步骤(18)的pUC57-GmU6-sgRNA质粒DNA,用EcoRI和HindIII酶(Fermentas)37℃双酶切过夜。酶切产物用PCR产物纯化试剂盒(Tiagen)进行纯化。(20) Take 100 ng of pCambia3301-Cas9 plasmid DNA from step (11) and 100 ng of pUC57-GmU6-sgRNA plasmid DNA from step (18), and double digest with EcoRI and HindIII enzymes (Fermentas) at 37°C overnight. The digested products were purified using a PCR product purification kit (Tiagen).
(21)取等体积步骤(20)的酶切纯化产物pCambia3301-Cas9和pUC57-GmU6-sgRNA,加入T4DNA连接酶、16℃连接过夜。(21) Take an equal volume of pCambia3301-Cas9 and pUC57-GmU6-sgRNA obtained from the digestion and purification of step (20), add T4 DNA ligase, and ligate overnight at 16°C.
(22)取2ul步骤(21)的连接产物,与50ul的DH10β感受态细胞混匀,冰上放置30分钟,42℃90秒,加入800ul LB液体培养基,37℃、200转培养50分钟,3000转离心、去上清,将沉淀的DH10β细胞重悬后均匀涂布于含有100ng/ml卡那青霉素的培养基中,37℃培养过夜。(22) Take 2ul of the ligation product of step (21), mix it with 50ul of DH10β competent cells, place it on ice for 30 minutes, add 800ul LB liquid medium for 90 seconds at 42°C, and incubate at 37°C and 200 rpm for 50 minutes. Centrifuge at 3000 rpm, remove the supernatant, resuspend the precipitated DH10β cells, spread evenly in the medium containing 100ng/ml kanapenicillin, and culture overnight at 37°C.
(23)挑取单菌落,用pCambia3301多克隆位点特异引物Pdmsf:(GGCTCGTATGTTGTGTGGAA)和pDMSR:(GCCTCTTCGCTATTACGCC)进行菌落PCR扩增验证插入片段。获得的阳性克隆即为pCas9-GmU6-sgRNA质粒,该质粒即为大豆CRISPR/Cas9体系。该体系中,根据目的基因设计的核心序列用于识别目的基因,cas9用于识别序列中的NGG序列,在NGG上游3-5bp处进行切割,造成DNA链的断裂,而生物体在修复DNA的过程中,会产生多种突变,从而对基因进行编辑修饰。(23) Pick a single colony, use pCambia3301 multiple cloning site-specific primers Pdmsf: (GGCTCGTATGTTGTGTGGAA) and pDMSR: (GCCTCTTCGCTATTACGCC) to perform colony PCR amplification to verify the insert. The obtained positive clone is the pCas9-GmU6-sgRNA plasmid, which is the soybean CRISPR/Cas9 system. In this system, the core sequence designed according to the target gene is used to identify the target gene, cas9 is used to recognize the NGG sequence in the sequence, and cuts at 3-5 bp upstream of NGG, causing DNA strand breaks, while the organism is repairing DNA. During the process, a variety of mutations will be generated to edit and modify the gene.
(24)挑取步骤(23)中的阳性克隆pCas9-GmU6-sgRNA,接种于50ml、卡那青霉素终浓度为100ng/ml的LB液体培养基中,37℃、200转速摇床中过夜培养。碱裂解法提取质粒后,用分光光度计调节质粒浓度至1ug/ul备用。(24) Pick the positive clone pCas9-GmU6-sgRNA in step (23), inoculate it in 50 ml of LB liquid medium with a final concentration of kanapenicillin of 100 ng/ml, and culture overnight at 37° C. in a shaker at 200 rpm. After extracting the plasmid by alkaline lysis, use a spectrophotometer to adjust the plasmid concentration to 1 ug/ul for later use.
实施例2Example 2
本实施例用于说明大豆CRISPR/Cas9体系对大豆基因修饰的功能验证。This example is used to illustrate the functional verification of soybean CRISPR/Cas9 system for soybean gene modification.
选取大豆三个基因Glyma06g14180,Glyma08g02290与Glyma12g37050为研究对象,引物合成序列如表1:Three soybean genes Glyma06g14180, Glyma08g02290 and Glyma12g37050 were selected as research objects, and the primer synthesis sequences are shown in Table 1:
表1:大豆目的基因引物设计Table 1: Design of primers for soybean target genes
由于是根据大豆目的基因设计的核心序列,从而构建的CRISPR/Cas9体系,因此CRISPR/Cas9体系中的核心序列可以对大豆目的基因进行识别,从而为cas9的修饰编辑功能提供定位。表1中,斜体为酶切位点,粗体为PAM序列,即NGG,cas9从NGG上游3-5bp处进行切割,因此切割正好发生在酶切位点处,为后期的验证试验提供了便利条件,即利用酶切试验,就可以看出是否发生了突变。Since the CRISPR/Cas9 system is constructed based on the core sequence designed based on the soybean target gene, the core sequence in the CRISPR/Cas9 system can recognize the soybean target gene, thereby providing a location for the modification and editing function of cas9. In Table 1, the italics are the enzyme cleavage site, the bold is the PAM sequence, that is, NGG, cas9 cuts from 3-5bp upstream of NGG, so the cleavage happens exactly at the enzyme cleavage site, which provides convenience for later verification experiments Conditions, that is, by using enzyme digestion test, it can be seen whether a mutation has occurred.
根据这三个基因构建的适用于这三个基因的CRISPR/Cas9体系,分别用大豆原生质体与子叶节发根法检测CRISPR/Cas9体系的活性。According to the CRISPR/Cas9 system suitable for these three genes constructed by these three genes, the activity of the CRISPR/Cas9 system was detected by soybean protoplast and cotyledonary node hairy root method respectively.
一、大豆原生质体检测CRISPR/Cas9体系的活性1. Detection of activity of CRISPR/Cas9 system by soybean protoplasts
(1)取新鲜大豆叶片,剪碎后放入裂解液中(0.5%cellulose R10,0.5%macerozymeR10,0.1%pectolase Y23,0.6M mannitol,10mM MES pH5.7,20mM KCl,10mM CaCl2and 0.1%BSA)。(1) Take fresh soybean leaves, cut them into pieces and put them into lysate (0.5% cellulose R10, 0.5% macerozyme R10, 0.1% pectolase Y23, 0.6M mannitol, 10mM MES pH5.7, 20mM KCl, 10mM CaCl2 and 0.1% BSA) .
(2)混匀后,真空抽滤30分钟。(2) After mixing, vacuum filter for 30 minutes.
(3)在30rpm条件下裂解约6小时。(3) Cleavage for about 6 hours under the condition of 30 rpm.
(4)用100μm尼龙膜过滤,100g离心3分钟,收集上清液。(4) Filter with a 100 μm nylon membrane, centrifuge at 100 g for 3 minutes, and collect the supernatant.
(5)加入等体积的W5溶液(2mM MES pH5.7,154mM NaCI,125mM CaCl2,5mM KCl),缓慢混匀,冰浴30分钟。(5) Add an equal volume of W5 solution (2mM MES pH 5.7, 154mM NaCI, 125mM CaCl 2 , 5mM KCl), mix slowly, and ice-bath for 30 minutes.
(6)100g离心3分钟,MMG溶液(4mM MES pH5.7,0.4mM mannitol,100mMCaCl2)重悬,待转化。(6) Centrifuge at 100 g for 3 minutes, resuspend in MMG solution (4 mM MES pH 5.7, 0.4 mM mannitol, 100 mM CaCl 2 ), and wait for transformation.
(7)100μl MMG重悬的原生质体溶液中加入10μl案例1步骤(24)的pCas9-GmU6-sgRNA质粒DNA,混匀后再加入110μl 40%PEG,缓慢混匀。室温下静置30分钟。(7) Add 10 μl of the pCas9-GmU6-sgRNA plasmid DNA in step (24) of Case 1 to 100 μl of the protoplast solution resuspended in MMG, mix well, then add 110 μl of 40% PEG, and mix slowly. Let stand at room temperature for 30 minutes.
(8)吸取800μl W5溶液漂洗后,加入1ml WI溶液(4mM MES pH5.7,0.5mMmannitol,20mM CaCl2),室温条件下,黑暗培养48小时。(8) After pipetting 800 μl of W5 solution for rinsing, add 1 ml of WI solution (4mM MES pH5.7, 0.5mMmannitol, 20mM CaCl 2 ), and incubate in the dark for 48 hours at room temperature.
(9)收集原生质体细胞,CTAB法提取原生质体基因组DNA。(9) Protoplast cells were collected, and the protoplast genomic DNA was extracted by CTAB method.
(10)将提取的基因组DNA用不同的内切酶(Glyma06g14180,Glyma08g02290和Glyma12g37050对应的内切酶分别为Pst I,BamHI和EcoRI)进行完全酶切,用基因特异引物对基因进行扩增、电泳检测(图2-4)。结果显示,当基因的酶切位点发生突变后,酶切位点消失,用相应的内切酶进行酶切时,突变的DNA为完整DNA,可以用基因特异性引物进行扩增出基因特异带;而对照DNA酶切后,由于存在酶切位点,基因DNA发生断裂,用基因特异引物无法扩增出基因特异带。(10) Complete digestion of the extracted genomic DNA with different endonucleases (Glyma06g14180, Glyma08g02290, and Glyma12g37050 corresponding endonucleases are Pst I, BamHI, and EcoRI, respectively), and the gene is amplified and electrophoresed with gene-specific primers Detection (Figure 2-4). The results show that when the restriction site of the gene is mutated, the restriction site disappears, and when the corresponding endonuclease is used for digestion, the mutated DNA is complete DNA, and gene-specific primers can be used to amplify the gene-specific DNA. However, after the control DNA was digested, the DNA of the gene was broken due to the existence of the restriction site, and the gene-specific band could not be amplified with the gene-specific primers.
(11)将步骤(10)的PCR产物克隆到pEasy-T载体(Transgene)上,挑取阳性克隆进行测序验证突变的位点。大豆原生质体法的三个基因编辑情况见SEQ ID No.1-SEQ ID No.16。(11) Cloning the PCR product of step (10) into the pEasy-T vector (Transgene), picking positive clones for sequencing to verify the mutation site. See SEQ ID No.1-SEQ ID No.16 for the three gene editing situations of the soybean protoplast method.
二、大豆子叶节诱导发根法检测CRISPR/Cas9体系的活性2. Detecting the activity of CRISPR/Cas9 system by the method of inducing hairy roots from soybean cotyledon nodes
(1)用氯气消毒法处理Williams 82大豆种子,将消毒的种子播种于灭菌的潮湿盒中,25℃,16小时光/8小时暗培养5天。(1) The Williams 82 soybean seeds were treated with chlorine gas disinfection, and the sterilized seeds were sown in a sterilized humid box, and cultured for 5 days at 25°C with 16 hours of light/8 hours of darkness.
(2)将构建好的pCas9-GmU6-sgRNA与pCas9-AtU6-sgRNA质粒,通过液氮速冻法转化到发根农杆菌K599中,在含有100ng/ml卡那青霉素、50ng/ml链霉素和50ng/ml壮观霉素抗性的固体MS培养基上28℃培养3天。(2) Transform the constructed pCas9-GmU6-sgRNA and pCas9-AtU6-sgRNA plasmids into Agrobacterium rhizogenes K599 by liquid nitrogen quick-freezing method, in the presence of 100ng/ml kanapenicillin, 50ng/ml streptomycin and 50ng/ml spectinomycin-resistant solid MS medium cultured at 28°C for 3 days.
(3)用注射器的针头挑取步骤(2)的菌落,将农杆菌K599直接插入到步骤(1)健康生长的大豆苗的子叶节下胚轴处。将感染K599的大豆苗放于密封的高湿度培养盒中,25℃,16小时光/8小时暗培养2-3周。(3) The colonies in step (2) were picked up with the needle of a syringe, and Agrobacterium K599 was directly inserted into the hypocotyl of the cotyledonary nodes of the soybean seedlings growing healthily in step (1). Soybean seedlings infected with K599 were placed in a sealed high-humidity culture box at 25°C, 16 hours light/8 hours dark culture for 2-3 weeks.
(4)当发状根从子叶节下胚轴处长至5-10厘米时,剪取单条发状根,CTAB法提取发状根基因组DNA。(4) When the hairy root grows to 5-10 cm from the hypocotyl of the cotyledonary node, a single hairy root is cut, and the hairy root genomic DNA is extracted by CTAB method.
(5)将基因组DNA用基因特异引物进行基因扩增,扩增的PCR产物用相应的内切酶进行酶切(Glyma06g14180,Glyma08g02290和Glyma12g37050对应的内切酶分别为Pst I,BamHI和EcoRI)电泳检测(图5-7)。以大豆叶片基因组DNA作为对照,结果有三种情况:(5) Genomic DNA is amplified with gene-specific primers, and the amplified PCR products are digested with corresponding endonucleases (the endonucleases corresponding to Glyma06g14180, Glyma08g02290, and Glyma12g37050 are PstI, BamHI, and EcoRI, respectively) electrophoresis Detection (Figure 5-7). Using soybean leaf genomic DNA as a control, the results have three situations:
显示两条带:目的基因PAM上游的3-5个碱基序列未改变或其它非预测序列发生变化;Two bands are displayed: the 3-5 nucleotide sequence upstream of the PAM of the target gene has not changed or other non-predicted sequences have changed;
仅显示一条带:双突变。因为大豆是双倍体植物,当基因组姐妹染色体都发生突变,由于酶切位点发生变化,导致内切酶无法发生酶切作用,因此显示一条带;Only one band is shown: double mutation. Because soybean is a diploid plant, when the sister chromosomes of the genome are mutated, due to the change of the enzyme cleavage site, the endonuclease cannot perform enzymatic cleavage, so a band is displayed;
显示三条带:单突变。单突变即在一条染色体上发生突变,而配对的另一条染色体没有突变,因此,酶切时,一条染色体DNA可以酶切,显示两条带,而另一条染色体DNA无法酶切,显示一条带,共三条带。Three bands are shown: single mutation. Single mutation refers to a mutation on one chromosome, while the other paired chromosome has no mutation. Therefore, during enzyme digestion, one chromosomal DNA can be digested and two bands are displayed, while the other chromosomal DNA cannot be digested and one band is displayed. There are three strips in total.
(6)用胶回收试剂盒(Tiagen)回收突变的DNA带,克隆到pEasy-T载体(Transgene)上,挑取阳性克隆进行测序验证突变的位点。从图中可以看出,每个目的基因都显示有多个突变情况,即条带不一。统计CRISPR/Cas9体系对目的基因的编辑情况,详见序列表中的基因片段,CRISPR/Cas9体系处理后的大豆基因确实发生了例如缺失、增加、替换等多种突变。大豆子叶节发根法的三个基因编辑情况见SEQ IDNo.17-SEQ ID No.28。(6) The mutated DNA band was recovered with a gel recovery kit (Tiagen), cloned into the pEasy-T vector (Transgene), and positive clones were picked for sequencing to verify the mutated site. It can be seen from the figure that each target gene shows multiple mutations, that is, the bands are different. For statistics on the editing of the target gene by the CRISPR/Cas9 system, see the gene fragments in the sequence listing for details. The soybean gene processed by the CRISPR/Cas9 system has indeed undergone various mutations such as deletion, addition, and substitution. See SEQ ID No.17-SEQ ID No.28 for the three gene editing methods of soybean cotyledonary node hairy root method.
可以说明,大豆原生质体法和大豆子叶节发根法,CRISPR/Cas9体系均可以对目的基因造成多种突变,突变率高。It can be shown that the soybean protoplast method, the soybean cotyledon node hair root method, and the CRISPR/Cas9 system can cause multiple mutations to the target gene, and the mutation rate is high.
对比例comparative example
采用实施例1的方法,同样构建带有拟南芥特异U6-26启动子的pCRISPR/Cas9体系,见图8。将构建的pCas9-AtU6-sgRNA同样对大豆原生质体法和大豆子叶节发根法这两种方法所得到的大豆基因组进行突变处理,处理方法同上。结果发现,Using the method of Example 1, a pCRISPR/Cas9 system with an Arabidopsis-specific U6-26 promoter was also constructed, as shown in FIG. 8 . The constructed pCas9-AtU6-sgRNA is also mutated to the soybean genome obtained by the two methods of soybean protoplast method and soybean cotyledonary node hairy root method, and the processing method is the same as above. turn out,
pCas9-GmU6-sgRNA体系的活性远高于pCas9-AtU6-sgRNA体系,目的基因突变率高达20.2%,详见表2,说明本专利申请构建的体系适用于大豆基因编辑修饰。The activity of the pCas9-GmU6-sgRNA system is much higher than that of the pCas9-AtU6-sgRNA system, and the target gene mutation rate is as high as 20.2%. See Table 2 for details, indicating that the system constructed in this patent application is suitable for soybean gene editing modification.
表2用两种体系对三个目的基因进行突变处理的结果比较Table 2 Comparison of the results of mutation treatment of three target genes with two systems
本发明所构建的大豆CRISPR/Cas9体系简单,对大豆基因修饰能够快速、高效的完成,克服了现有的ZFNs体系过于复杂,费时且效率低的问题。The soybean CRISPR/Cas9 system constructed by the present invention is simple, and the soybean genetic modification can be completed quickly and efficiently, which overcomes the problems that the existing ZFNs system is too complicated, time-consuming and inefficient.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410730236.0A CN104450774A (en) | 2014-12-04 | 2014-12-04 | Construction of soybean CRISPR/Cas9 system and application of soybean CRISPR/Cas9 system in soybean gene modification |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410730236.0A CN104450774A (en) | 2014-12-04 | 2014-12-04 | Construction of soybean CRISPR/Cas9 system and application of soybean CRISPR/Cas9 system in soybean gene modification |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104450774A true CN104450774A (en) | 2015-03-25 |
Family
ID=52897523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410730236.0A Pending CN104450774A (en) | 2014-12-04 | 2014-12-04 | Construction of soybean CRISPR/Cas9 system and application of soybean CRISPR/Cas9 system in soybean gene modification |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104450774A (en) |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9228207B2 (en) | 2013-09-06 | 2016-01-05 | President And Fellows Of Harvard College | Switchable gRNAs comprising aptamers |
CN105316327A (en) * | 2015-11-03 | 2016-02-10 | 中国农业科学院作物科学研究所 | Wheat TaAGO4a gene CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats)/-CRISPR-associated protein 9) vector and application thereof |
US9322006B2 (en) | 2011-07-22 | 2016-04-26 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
US9388430B2 (en) | 2013-09-06 | 2016-07-12 | President And Fellows Of Harvard College | Cas9-recombinase fusion proteins and uses thereof |
US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
CN106636182A (en) * | 2016-10-21 | 2017-05-10 | 山西省农业科学院蔬菜研究所 | Construction of CRISPR-Cas9 system of tomato PSY 1 gene and application thereof |
US9834791B2 (en) | 2013-11-07 | 2017-12-05 | Editas Medicine, Inc. | CRISPR-related methods and compositions with governing gRNAS |
US9840699B2 (en) | 2013-12-12 | 2017-12-12 | President And Fellows Of Harvard College | Methods for nucleic acid editing |
US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
CN108588128A (en) * | 2018-04-26 | 2018-09-28 | 南昌大学 | A kind of construction method of high efficiency soybean CRISPR/Cas9 systems and application |
US10113163B2 (en) | 2016-08-03 | 2018-10-30 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
US10167457B2 (en) | 2015-10-23 | 2019-01-01 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
CN109628481A (en) * | 2019-01-02 | 2019-04-16 | 吉林农业大学 | Soya bean fatty acid desaturase polygenes CRISPR/Cas9 vector construction and application |
US10508298B2 (en) | 2013-08-09 | 2019-12-17 | President And Fellows Of Harvard College | Methods for identifying a target site of a CAS9 nuclease |
CN111254159A (en) * | 2018-11-30 | 2020-06-09 | 东北农业大学 | Soybean GmST1 gene mutant plant and preparation method thereof |
US10745677B2 (en) | 2016-12-23 | 2020-08-18 | President And Fellows Of Harvard College | Editing of CCR5 receptor gene to protect against HIV infection |
US11268082B2 (en) | 2017-03-23 | 2022-03-08 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable DNA binding proteins |
US11306324B2 (en) | 2016-10-14 | 2022-04-19 | President And Fellows Of Harvard College | AAV delivery of nucleobase editors |
US11319532B2 (en) | 2017-08-30 | 2022-05-03 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
US11447770B1 (en) | 2019-03-19 | 2022-09-20 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
US11542496B2 (en) | 2017-03-10 | 2023-01-03 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
US11795443B2 (en) | 2017-10-16 | 2023-10-24 | The Broad Institute, Inc. | Uses of adenosine base editors |
US11898179B2 (en) | 2017-03-09 | 2024-02-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
US11912985B2 (en) | 2020-05-08 | 2024-02-27 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
US12157760B2 (en) | 2018-05-23 | 2024-12-03 | The Broad Institute, Inc. | Base editors and uses thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103668472A (en) * | 2013-12-31 | 2014-03-26 | 北京大学 | Method for constructing eukaryon gene knockout library by using CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9 system |
CN104017821A (en) * | 2014-05-16 | 2014-09-03 | 安徽省农业科学院水稻研究所 | Method for directionally editing chaff-color-determining gene OsCHI for creating brown-chaff rice material |
-
2014
- 2014-12-04 CN CN201410730236.0A patent/CN104450774A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103668472A (en) * | 2013-12-31 | 2014-03-26 | 北京大学 | Method for constructing eukaryon gene knockout library by using CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9 system |
CN104017821A (en) * | 2014-05-16 | 2014-09-03 | 安徽省农业科学院水稻研究所 | Method for directionally editing chaff-color-determining gene OsCHI for creating brown-chaff rice material |
Non-Patent Citations (1)
Title |
---|
THOMAS B. JACOBS等: "A comparison of ta-siRNA and CRISPR/Cas9 mediated gene silencing systems in soybean", 《INTERNATIONAL PLANT & ANIMAL GENOME CONFERENCE》 * |
Cited By (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12006520B2 (en) | 2011-07-22 | 2024-06-11 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
US10323236B2 (en) | 2011-07-22 | 2019-06-18 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
US9322006B2 (en) | 2011-07-22 | 2016-04-26 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
US10508298B2 (en) | 2013-08-09 | 2019-12-17 | President And Fellows Of Harvard College | Methods for identifying a target site of a CAS9 nuclease |
US10954548B2 (en) | 2013-08-09 | 2021-03-23 | President And Fellows Of Harvard College | Nuclease profiling system |
US11920181B2 (en) | 2013-08-09 | 2024-03-05 | President And Fellows Of Harvard College | Nuclease profiling system |
US10227581B2 (en) | 2013-08-22 | 2019-03-12 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
US11046948B2 (en) | 2013-08-22 | 2021-06-29 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
US9737604B2 (en) | 2013-09-06 | 2017-08-22 | President And Fellows Of Harvard College | Use of cationic lipids to deliver CAS9 |
US9228207B2 (en) | 2013-09-06 | 2016-01-05 | President And Fellows Of Harvard College | Switchable gRNAs comprising aptamers |
US9388430B2 (en) | 2013-09-06 | 2016-07-12 | President And Fellows Of Harvard College | Cas9-recombinase fusion proteins and uses thereof |
US9999671B2 (en) | 2013-09-06 | 2018-06-19 | President And Fellows Of Harvard College | Delivery of negatively charged proteins using cationic lipids |
US10912833B2 (en) | 2013-09-06 | 2021-02-09 | President And Fellows Of Harvard College | Delivery of negatively charged proteins using cationic lipids |
US9340800B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | Extended DNA-sensing GRNAS |
US10858639B2 (en) | 2013-09-06 | 2020-12-08 | President And Fellows Of Harvard College | CAS9 variants and uses thereof |
US10682410B2 (en) | 2013-09-06 | 2020-06-16 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
US10597679B2 (en) | 2013-09-06 | 2020-03-24 | President And Fellows Of Harvard College | Switchable Cas9 nucleases and uses thereof |
US11299755B2 (en) | 2013-09-06 | 2022-04-12 | President And Fellows Of Harvard College | Switchable CAS9 nucleases and uses thereof |
US9834791B2 (en) | 2013-11-07 | 2017-12-05 | Editas Medicine, Inc. | CRISPR-related methods and compositions with governing gRNAS |
US10640788B2 (en) | 2013-11-07 | 2020-05-05 | Editas Medicine, Inc. | CRISPR-related methods and compositions with governing gRNAs |
US11390887B2 (en) | 2013-11-07 | 2022-07-19 | Editas Medicine, Inc. | CRISPR-related methods and compositions with governing gRNAS |
US10190137B2 (en) | 2013-11-07 | 2019-01-29 | Editas Medicine, Inc. | CRISPR-related methods and compositions with governing gRNAS |
US9840699B2 (en) | 2013-12-12 | 2017-12-12 | President And Fellows Of Harvard College | Methods for nucleic acid editing |
US10465176B2 (en) | 2013-12-12 | 2019-11-05 | President And Fellows Of Harvard College | Cas variants for gene editing |
US11053481B2 (en) | 2013-12-12 | 2021-07-06 | President And Fellows Of Harvard College | Fusions of Cas9 domains and nucleic acid-editing domains |
US12215365B2 (en) | 2013-12-12 | 2025-02-04 | President And Fellows Of Harvard College | Cas variants for gene editing |
US11124782B2 (en) | 2013-12-12 | 2021-09-21 | President And Fellows Of Harvard College | Cas variants for gene editing |
US10704062B2 (en) | 2014-07-30 | 2020-07-07 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
US11578343B2 (en) | 2014-07-30 | 2023-02-14 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
US10167457B2 (en) | 2015-10-23 | 2019-01-01 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
US11214780B2 (en) | 2015-10-23 | 2022-01-04 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
US12043852B2 (en) | 2015-10-23 | 2024-07-23 | President And Fellows Of Harvard College | Evolved Cas9 proteins for gene editing |
CN105316327A (en) * | 2015-11-03 | 2016-02-10 | 中国农业科学院作物科学研究所 | Wheat TaAGO4a gene CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats)/-CRISPR-associated protein 9) vector and application thereof |
CN105316327B (en) * | 2015-11-03 | 2019-01-29 | 中国农业科学院作物科学研究所 | Wheat TaAGO4a gene C RISPR/Cas9 carrier and its application |
US10113163B2 (en) | 2016-08-03 | 2018-10-30 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
US11999947B2 (en) | 2016-08-03 | 2024-06-04 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
US11702651B2 (en) | 2016-08-03 | 2023-07-18 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
US10947530B2 (en) | 2016-08-03 | 2021-03-16 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
US12084663B2 (en) | 2016-08-24 | 2024-09-10 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
US11306324B2 (en) | 2016-10-14 | 2022-04-19 | President And Fellows Of Harvard College | AAV delivery of nucleobase editors |
CN106636182A (en) * | 2016-10-21 | 2017-05-10 | 山西省农业科学院蔬菜研究所 | Construction of CRISPR-Cas9 system of tomato PSY 1 gene and application thereof |
CN106636182B (en) * | 2016-10-21 | 2019-11-08 | 山西省农业科学院蔬菜研究所 | A kind of CRISPR-Cas9 system construction of 1 gene of tomato PSY and its application |
US11820969B2 (en) | 2016-12-23 | 2023-11-21 | President And Fellows Of Harvard College | Editing of CCR2 receptor gene to protect against HIV infection |
US10745677B2 (en) | 2016-12-23 | 2020-08-18 | President And Fellows Of Harvard College | Editing of CCR5 receptor gene to protect against HIV infection |
US11898179B2 (en) | 2017-03-09 | 2024-02-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
US11542496B2 (en) | 2017-03-10 | 2023-01-03 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
US11268082B2 (en) | 2017-03-23 | 2022-03-08 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable DNA binding proteins |
US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
US11319532B2 (en) | 2017-08-30 | 2022-05-03 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
US11932884B2 (en) | 2017-08-30 | 2024-03-19 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
US11795443B2 (en) | 2017-10-16 | 2023-10-24 | The Broad Institute, Inc. | Uses of adenosine base editors |
CN108588128A (en) * | 2018-04-26 | 2018-09-28 | 南昌大学 | A kind of construction method of high efficiency soybean CRISPR/Cas9 systems and application |
US12157760B2 (en) | 2018-05-23 | 2024-12-03 | The Broad Institute, Inc. | Base editors and uses thereof |
CN111254159A (en) * | 2018-11-30 | 2020-06-09 | 东北农业大学 | Soybean GmST1 gene mutant plant and preparation method thereof |
CN109628481A (en) * | 2019-01-02 | 2019-04-16 | 吉林农业大学 | Soya bean fatty acid desaturase polygenes CRISPR/Cas9 vector construction and application |
US11795452B2 (en) | 2019-03-19 | 2023-10-24 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
US11643652B2 (en) | 2019-03-19 | 2023-05-09 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
US11447770B1 (en) | 2019-03-19 | 2022-09-20 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
US11912985B2 (en) | 2020-05-08 | 2024-02-27 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
US12031126B2 (en) | 2020-05-08 | 2024-07-09 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104450774A (en) | Construction of soybean CRISPR/Cas9 system and application of soybean CRISPR/Cas9 system in soybean gene modification | |
Du et al. | Efficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9 | |
US11459576B2 (en) | Methods for producing a complex transgenic trait locus | |
Iaffaldano et al. | CRISPR/Cas9 genome editing of rubber producing dandelion Taraxacum kok-saghyz using Agrobacterium rhizogenes without selection | |
CN104846010B (en) | A kind of method for deleting transgenic paddy rice riddled basins | |
US11041165B2 (en) | Identification of a Xanthomonas euvesicatoria resistance gene from pepper (Capsicum annuum) and method for generating plants with resistance | |
WO2017028768A1 (en) | Method for obtaining glyphosate-resistant rice by site-directed nucleotide substitution | |
CN109652422B (en) | Efficient single base editing system OsSpCas9-eCDA and its application | |
US20170058295A1 (en) | Methods and compositions for producing male sterile plants | |
CA3043774A1 (en) | A method for base editing in plants | |
CN107406858A (en) | Compositions and methods for directing regulated expression of RNA/CAS endonuclease complexes | |
WO2016186953A1 (en) | Guide rna/cas endonuclease systems | |
BR112016003776B1 (en) | POLYNUCLEOTIDE, PLANT OR SEED, POLYNUCLEOTIDE COMPLEX, METHOD FOR MODIFYING A TARGET SITE IN THE GENOME OF A CELL, METHOD FOR INTRODUCING A POLYNUCLEOTIDE OF INTEREST, METHOD FOR EDITING A NUCLEOTIDE SEQUENCE, PLANT CELL, METHOD FOR SELECTING A PLANT | |
WO2016007347A1 (en) | Compositions and methods for producing plants resistant to glyphosate herbicide | |
CN111511199A (en) | Improved blue aleurone and other separation systems | |
WO2021026081A2 (en) | Rna guide genome editing in citrus using crispr-ribonucleoprotein complexes | |
Pathak et al. | Dual-targeting by CRISPR/Cas9 leads to efficient point mutagenesis but only rare targeted deletions in the rice genome | |
WO2017040768A1 (en) | Citrus varieties resistant to xanthomonas citri infection | |
KR102516522B1 (en) | pPLAⅡη gene inducing haploid plant and uses thereof | |
CN102517284B (en) | Promoter miR390 and applications thereof | |
CN107435044A (en) | The promoter of paddy rice stamen specifically expressing and its application | |
CN115960899A (en) | Tea tree CsU6 gene promoter and cloning and application thereof | |
Flaishman et al. | Advanced molecular tools for breeding in Mediterranean fruit trees: genome editing approach of Ficus carica L. | |
Sam et al. | DESIGN AND TRANSFER OF OsSWEET14-EDITING T-DNA CONSTRUCT TO BAC THOM 7 RICE CULTIVAR. | |
CN109913450B (en) | Promoter pSSP3 specifically expressed in rice stamen and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150325 |
|
WD01 | Invention patent application deemed withdrawn after publication |